Live Quote · NASDAQCELZHealthcare· Biotechnology

Creative Medical Technology Holdings, Inc.

$1.21 4.72%($-0.06)
TickerSpark Score
54/100
Mixed
80
Valuation
20
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CELZ research report →

52-Week Range8% of range
Low
$0.79
Current
$1.21
High
$6.25

About the company

Creative Medical Technology Holdings, Inc. , a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology.

CEO
Timothy Warbington
IPO
2015
Employees
4
HQ
Phoenix, AZ, US

Price Chart

-54.68% · this period
$5.59$3.20$0.81Jul 02Dec 31Jul 02
Valuation
Market Cap
$3.12M
P/E
-0.58
P/S
1040.87
P/B
0.73
EV/EBITDA
0.45
Div Yield
0.00%
Profitability
Gross Margin
-1993.17%
Op Margin
-198049.63%
Net Margin
-192066.27%
ROE
-88.50%
ROIC
-96.88%
Growth & Income
Revenue
$6.00K · -45.45%
Net Income
$-5,995,008 · -9.13%
EPS
$-2.52 · 32.08%
Op Income
$-6,142,814
FCF YoY
-10.47%
Performance & Tape
52W High
$6.25
52W Low
$0.79
50D MA
$2.11
200D MA
$2.41
Beta
1.88
Avg Volume
3.26M

Get TickerSpark's AI analysis on CELZ

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Feb 18, 25Finger Michael H.sell750
Feb 19, 25Finger Michael H.sell750
Jun 28, 23Warbington Timothybuy200
Jun 27, 23Warbington Timothybuy200
Jun 27, 23Warbington Timothybuy300
Jun 27, 23Warbington Timothybuy300
Nov 22, 22Warbington Timothybuy200
Nov 22, 22Warbington Timothybuy9,800
Nov 21, 22Warbington Timothybuy5,000
Nov 21, 22Warbington Timothybuy10,000
Coverage · CELZ

Our CELZ coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on CELZ yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate CELZ report →
Internal Compare

Similar companies

Peers in the same neighborhood.